Skip to content

R&D at other companies

OSI Systems logo
OSI SystemsOSIS
$19.46M+4.8%
iRadimed logo
iRadimedIRMD
$956K+53.2%
HTF
Heartflow, Inc. Common StockHTFL
$21.62M+55.3%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$39.38M+8.4%
Butterfly Network logo
Butterfly NetworkBFLY
$9.54M-3.9%
QT Imaging Holdings, Inc. logo
QT Imaging Holdings, Inc.QTI
$1.72M+102%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.12B-13.0%
P/E15.2×+0.3×
P/S1.4×-0.3×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's R&D?
GE HealthCare Technologies (GEHC) reported R&D of $345M in Q1 2026.
How has GE HealthCare Technologies's R&D changed year-over-year?
GE HealthCare Technologies's R&D increased by 0.3% year-over-year, from $344M to $345M.
What is the long-term trend for GE HealthCare Technologies's R&D?
Over 4 years (2021 to 2025), GE HealthCare Technologies's R&D has grown at a 11.5% compound annual growth rate (CAGR), from $816M to $1.26B.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.